Direct-to-Consumer Alzheimer’s Blood Test Opens Pandora’s Box

News
Written By Knapsack

From AlzForum

  • Quest Diagnostics is selling an AD blood test directly to consumers.

  • No peer-reviewed data are published on the test.

  • It has low specificity, potentially generating many false-positive results.

  • Experts fear it will do more harm than good.

 

The first direct-to-consumer Alzheimer’s disease blood test has arrived. Quest Diagnostics, a worldwide diagnostic service headquartered in Secaucus, New Jersey, announced on July 31 that it would market a plasma Aβ42/ Aβ40 Alzheimer’s test to the public.

Knapsack http://www.knapsackcreative.com
Previous

Experts raise concerns about Quest Diagnostics’ consumer-initiated Alzheimer’s test
Next

Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape